The effect of autologous bone marrow mononuclear cells on duration of survival in Amyotrophic Lateral Sclerosis patients.
Survival duration in Amyotrophic Lateral Sclerosis patients who received cellular transplantation was compared to patients who did not receive cellular transplantation. Kaplan-Meier survival analysis was used for this comparison.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Autologous bone marrow derived mononuclear cells were administered via intrathecal and intramuscular routes.
Neurogen brain and spine institute
Mumbai, Maharashtra, India
Duration of survival
Time frame: 56 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.